ENTRY       D12540                      Drug
NAME        Briquilimab (USAN/INN)
FORMULA     C6426H9946N1718O2034S46
EXACT_MASS  145197.4805
MOL_WEIGHT  145287.0096
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYNMHWVRQA PGQGLEWMGV IYSGNGDTSY
            NQKFKGRVTI TADKSTSTAY MELSSLRSED TAVYYCARER DTRFGNWGQG TLVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYQSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            DIVMTQSPDS LAVSLGERAT INCRASESVD IYGNSFMHWY QQKPGQPPKL LIYLASNLES
            GVPDRFSGSG SGTDFTLTIS SLQAEDVAVY YCQQNNEDPY TFGGGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide biride: H22-H96, H144-H200, H220-L218, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'96, H'144-H'200, H'220-L'218, H'261-H'321, H'367-H'425, L23-L92, L138-L198, L'23-L'92, L'138-L'198)
  TYPE      Peptide
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
EFFICACY    Immunomodulator, Receptor tyrosine kinase inhibitor
  TYPE      Monoclonal antibody
COMMENT     Conditioning agent, to be used prior to hematopoietic cell diseases
TARGET      KIT (CD117) [HSA:3815] [KO:K05091]
  PATHWAY   hsa04010(3815)  MAPK signaling pathway
            hsa04151(3815)  PI3K-Akt signaling pathway
            hsa04640(3815)  Hematopoietic cell lineage
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                D12540  Briquilimab
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               PDGFR family
                KIT (CD117)
                 D12540  Briquilimab (USAN/INN)
DBLINKS     CAS: 2574591-89-0
///
